Pages that link to "Q61628153"
Jump to navigation
Jump to search
The following pages link to Increased levels of soluble tumor necrosis factor receptors in the sera and synovial fluid of patients with rheumatic diseases (Q61628153):
Displaying 50 items.
- JNK1 is not essential for TNF-mediated joint disease (Q24799357) (← links)
- Colocalization of endogenous TNF with a functional intracellular splice form of human TNF receptor type 2. (Q24811065) (← links)
- Polymorphism in the tumour necrosis factor receptor II gene is associated with circulating levels of soluble tumour necrosis factor receptors in rheumatoid arthritis (Q24812785) (← links)
- Levels of gastrin-releasing peptide and substance P in synovial fluid and serum correlate with levels of cytokines in rheumatoid arthritis. (Q24816519) (← links)
- The cybernetics of TNF: Old views and newer ones (Q26782229) (← links)
- Immune markers measured before treatment predict outcome of intensive phase tuberculosis therapy (Q28396491) (← links)
- Effect of soluble P55 tumour-necrosis factor binding fusion protein on the local Shwartzman and Arthus reactions (Q30443950) (← links)
- Etanercept, a novel drug for the treatment of patients with severe, active rheumatoid arthritis (Q33544863) (← links)
- Serum p55 and p75 tumour necrosis factor receptors as markers of disease activity in juvenile chronic arthritis (Q33578865) (← links)
- Etanercept: a review of its use in rheumatoid arthritis (Q33684274) (← links)
- Early diagnosis and treatment of rheumatoid arthritis for improved outcomes: focus on etanercept, a new biologic response modifier (Q33748639) (← links)
- The function of tumour necrosis factor and receptors in models of multi-organ inflammation, rheumatoid arthritis, multiple sclerosis and inflammatory bowel disease (Q33782327) (← links)
- Etanercept: therapeutic use in patients with rheumatoid arthritis (Q33782355) (← links)
- Soluble tumor necrosis factor alpha receptors in sera from leprosy patients. (Q34000080) (← links)
- Modulation of T cell proliferation and cytokine response by Plumbagin, extracted from Plumbago zeylanica in collagen induced arthritis (Q34074849) (← links)
- Therapy of rheumatoid arthritis: new developments and trends (Q34108776) (← links)
- Increased concentrations of tumour necrosis factor (TNF) and soluble TNF receptors in biliary obstruction in mice; soluble TNF receptors as prognostic factors for mortality (Q34409484) (← links)
- Anti-TNF therapy for rheumatoid arthritis and other inflammatory diseases (Q34450313) (← links)
- Tumour necrosis factor (TNF) in psoriatic arthritis: pathophysiology and treatment with TNF inhibitors (Q34550167) (← links)
- Signaling to gene activation and cell death by tumor necrosis factor receptors and Fas. (Q34563012) (← links)
- Studies of T-cell activation in chronic inflammation (Q34731209) (← links)
- Kallikrein cascade and cytokines in inflamed joints (Q34792751) (← links)
- Cytokines and anti-cytokine biologicals in autoimmunity: present and future (Q34830551) (← links)
- Etanercept: an updated review of its use in rheumatoid arthritis, psoriatic arthritis and juvenile rheumatoid arthritis (Q34991484) (← links)
- Secretion imbalance between tumour necrosis factor and its inhibitor in inflammatory bowel disease (Q35351969) (← links)
- Serum interleukin 12 concentration in juvenile chronic arthritis (Q35547995) (← links)
- Human, viral or mutant human IL-10 expressed after local adenovirus-mediated gene transfer are equally effective in ameliorating disease pathology in a rabbit knee model of antigen-induced arthritis (Q35605628) (← links)
- Expanding the armamentarium for the spondyloarthropathies (Q35823657) (← links)
- Effects of Antitumor Necrosis Factor Therapy on Osteoprotegerin, Neopterin, and sRANKL Concentrations in Patients with Rheumatoid Arthritis. (Q36245404) (← links)
- A metalloprotease inhibitor blocks shedding of the 80-kD TNF receptor and TNF processing in T lymphocytes (Q36364492) (← links)
- A critical role of the p75 tumor necrosis factor receptor (p75TNF-R) in organ inflammation independent of TNF, lymphotoxin alpha, or the p55TNF-R. (Q36401608) (← links)
- Arthritis suppressor genes TIA-1 and TTP dampen the expression of tumor necrosis factor alpha, cyclooxygenase 2, and inflammatory arthritis (Q36604460) (← links)
- Shedding of TNF receptor 2 by effector CD8⁺ T cells by ADAM17 is important for regulating TNF-α availability during influenza infection (Q36606971) (← links)
- Tumour necrosis factor receptor 1 and mortality in a multi-ethnic cohort: the Northern Manhattan Study (Q36956740) (← links)
- Immunopathological mechanisms in dogs with rupture of the cranial cruciate ligament (Q37214074) (← links)
- Biomarkers of inflammation and development of rheumatoid arthritis in women from two prospective cohort studies (Q37273372) (← links)
- Shedding kinetics of soluble tumor necrosis factor (TNF) receptors after systemic TNF leaking during isolated limb perfusion. Relevance to the pathophysiology of septic shock. (Q37378024) (← links)
- A clinical trial and extension study of infliximab in Korean patients with active rheumatoid arthritis despite methotrexate treatment. (Q37378732) (← links)
- TNF Receptor 2 and Disease: Autoimmunity and Regenerative Medicine (Q37408682) (← links)
- 99mTc-labelled S-HYNIC certolizumab pegol in rheumatoid arthritis and spondyloarthritis patients: a biodistribution and dosimetry study (Q37494175) (← links)
- TNF receptor 2 pathway: drug target for autoimmune diseases (Q37758202) (← links)
- Current understanding of rheumatoid arthritis therapy (Q37987351) (← links)
- Regulation of TNF-α with a focus on rheumatoid arthritis (Q38102876) (← links)
- Strategies for active TNF-α vaccination in rheumatoid arthritis treatment (Q38120922) (← links)
- Synovial fluid proteome in rheumatoid arthritis (Q38856510) (← links)
- Paradoxical effects of a synthetic metalloproteinase inhibitor that blocks both p55 and p75 TNF receptor shedding and TNF alpha processing in RA synovial membrane cell cultures (Q39766387) (← links)
- A cytotoxic nonstructural protein, NS1, of human parvovirus B19 induces activation of interleukin-6 gene expression (Q39877191) (← links)
- Monoclonal anti‐TNFα Antibody as a Probe of Pathogenesis and Therapy of Rheumatoid Disease (Q40433213) (← links)
- Beneficial effects of tumour necrosis factor-alpha (TNF-α) blockade in rheumatoid arthritis (RA) (Q40467512) (← links)
- Immunological intervention reveals reciprocal roles for tumor necrosis factor-alpha and interleukin-10 in rheumatoid arthritis and systemic lupus erythematosus (Q40506587) (← links)